Our partners and clients
We are proud to collaborate with a diverse range of partners and clients across various industries. Our commitment to excellence and innovation has helped us build strong relationships with businesses worldwide.
What Our Partners and Clients Say About Us
We value the feedback from our partners and clients and strive to exceed their expectations. Here's what some of them have to say about their experience working with us.
"The team at SLS Ventures brings decades of business and strategic experience to our team. Mirko Stange was essential when founding Elastrin Therapeutics and Klaus-Dieter Langner adds a unique pharma expertise as one of our Board Members."

Dr. Matthias Breugelmans
CEO Elastrin Therapeutics
"The team at SLS Ventures brings decades of business and strategic experience to our team. Mirko Stange was essential when founding Elastrin Therapeutics and Klaus-Dieter Langner adds a unique pharma expertise as one of our Board Members."

Dr. Matthias Breugelmans
CEO Elastrin Therapeutics
"The team at SLS Ventures brings decades of business and strategic experience to our team. Mirko Stange was essential when founding Elastrin Therapeutics and Klaus-Dieter Langner adds a unique pharma expertise as one of our Board Members."

Dr. Matthias Breugelmans
CEO Elastrin Therapeutics
"The team at SLS Ventures brings decades of business and strategic experience to our team. Mirko Stange was essential when founding Elastrin Therapeutics and Klaus-Dieter Langner adds a unique pharma expertise as one of our Board Members."

Dr. Matthias Breugelmans
CEO Elastrin Therapeutics
"The team at SLS Ventures brings decades of business and strategic experience to our team. Mirko Stange was essential when founding Elastrin Therapeutics and Klaus-Dieter Langner adds a unique pharma expertise as one of our Board Members."

Dr. Matthias Breugelmans
CEO Elastrin Therapeutics
"The team at SLS Ventures brings decades of business and strategic experience to our team. Mirko Stange was essential when founding Elastrin Therapeutics and Klaus-Dieter Langner adds a unique pharma expertise as one of our Board Members."

Dr. Matthias Breugelmans
CEO Elastrin Therapeutics